Skip to main content
. 2020 Oct 19;22(6):5348–5357. doi: 10.3892/mmr.2020.11614

Figure 3.

Figure 3.

Statistical analysis of immunohistochemistry data showed that the percentage of A1R-positive cells was significantly increased in the SE group compared with the con group. Treatment with the p38 MAPK inhibitor SB203580 (15 mg/kg) decreased the expression levels of A1R compared with SE group. n=5 in each group. *P<0.05 vs. con; #P<0.05 vs. SE. A1R, adenosine A1 receptor; SE, status epilepticus; con, control.